SCHEMBL1702664

SCHEMBL1702664

Cc1cc(N(c2ccccc2)c2ccccc2C)ccc1-c1ccc(N(c2ccccc2)c2ccccc2C)cc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.35
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ESR2 Q92731 1/20 0.34
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
APP P05067 1/20 0.33
HDAC6 Q9UBN7 1/20 0.32
RPS6KA2 Q15349 1/20 0.31
LMNA P02545 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.31
TSHR P16473 2/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17734613 0.92 ESR2 (0.39) L3MBTL1MAPTESR2HSD17B1HSD17B2
SCHEMBL11330854 0.91 PTPRC (0.34) CYP3A4ALDH1A1CYP1A2MAPTCYP2C19
SCHEMBL11330069 0.91 HSD17B1 (0.35) CYP3A4ESR2HSD17B1HSD17B2LMNA
SCHEMBL17734616 0.89 ESR2 (0.37) L3MBTL1KDM4EMAPTESR2HSD17B1
SCHEMBL11321702 0.88 HSD17B1 (0.36) CYP3A4ALDH1A1CYP1A2MAPTCYP2C9
SCHEMBL1702523 0.87 ALDH1A1 (0.46) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL8943827 0.87 ALDH1A1 (0.44) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL17734603 0.85 ESR2 (0.42) CYP3A4ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL17734599 0.85 CYP2A6 (0.37) ALDH1A1L3MBTL1CYP1A2TDP1ESR2
SCHEMBL17734621 0.85 KMT2A (0.31) HSD17B1HSD17B2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150037732-A1 METHOD FOR MANUFACTURING PHOTORECEPTOR LAYERS XEROX CORPORATION (US) 2015-02-05 US claimed
US-7267917-B2 Photoreceptor charge transport layer composition XEROX CORPORATION (US) 2007-09-11 US claimed
US-20060063080-A1 Photoreceptor charge transport layer composition XEROX CORPORATION (US) 2006-03-23 US claimed
US-6645686-B1 Electrophotographic imaging members XEROX CORPORATION 2003-11-11 US claimed
US-5610213-A POLYSILOXANES GENERAL ELECTRIC COMPANY (US) 1997-03-11 US claimed
US-4299897-A Aromatic amino charge transport layer in electrophotography XEROX CORPORATION (US) 1981-11-10 US claimed
US-4047948-A Composite layered imaging member for electrophotography XEROX CORPORATION (US) 1977-09-13 US claimed
US-20160133847-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-05-12 US disclosed
US-20160133847-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-05-12 US disclosed
US-20150037732-A1 METHOD FOR MANUFACTURING PHOTORECEPTOR LAYERS XEROX CORPORATION (US) 2015-02-05 US disclosed
EP-1089130-B1 Process for fabricating an electrophotographic imaging member XEROX CORP (US) 2012-04-18 EP disclosed
US-7811728-B2 Imaging members and process for preparing same XEROX CORPORATION (US) 2010-10-12 US disclosed
US-7704656-B2 Photoconductive imaging member XEROX CORPORATION (US) 2010-04-27 US disclosed
US-4427452-A SILANE-TREATED KAOLINIC CLAY ENGLISH CLAYS LOVERING POCHIN & COMPANY LIMITED (GB) 1984-01-24 US disclosed
US-4299897-A Aromatic amino charge transport layer in electrophotography XEROX CORPORATION (US) 1981-11-10 US disclosed
US-4281054-A Overcoated photoreceptor containing injecting contact XEROX CORPORATION (US) 1981-07-28 US disclosed
US-4081274-A Composite layered photoreceptor XEROX CORPORATION (US) 1978-03-28 US disclosed
US-4078925-A Composite layered photoreceptor XEROX CORPORATION (US) 1978-03-14 US disclosed
US-4047948-A Composite layered imaging member for electrophotography XEROX CORPORATION (US) 1977-09-13 US disclosed
US-4047949-A Composite layered imaging member for electrophotography XEROX CORPORATION (US) 1977-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160133847-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT ARL1, CCNL2, APOL1 CYP3A4 1604/4885ALDH1A1 466/4885L3MBTL1 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.